Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BLTE

Belite Bio Inc ADR

May 29 • 04:00PM ET

144.18

-3.82 -2.58 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM KRYS MIRM VKTX KYMR MDGL NUVL AXSM NBIX

| Held by: SPEM ONEQ APIE GXC BBC EHLS TNXT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.53	Insider Own	1.27%	Shs Outstand	40.09M	Perf Week	-0.05%
Market Cap	5.78B	Forward P/E	170.63	EPS next Y	0.84	Insider Trans	-6.12%	Shs Float	39.57M	Perf Month	-6.68%
Enterprise Value	5.50B	PEG	-	EPS next Q	-0.75	Inst Own	22.44%	Short Float	3.01%	Perf Quarter	-24.24%
Income	-90.27M	P/S	-	EPS this Y	-37.93%	Inst Trans	5.63%	Short Ratio	7.51	Perf Half Y	12.82%
Sales	0.00M	P/B	7.26	EPS next Y	126.52%	ROA	-18.51%	Short Interest	1.19M	Perf YTD	-9.86%
Book/sh	19.85	P/C	20.91	EPS next 5Y	-	ROE	-18.93%	52W High	200.00 -27.91%	Perf Year	119.65%
Cash/sh	6.89	P/FCF	-	EPS past 3/5Y	-54.04% -549.64%	ROIC	-11.71%	52W Low	56.10 157.01%	Perf 3Y	520.13%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.40% 4.99%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-85.65%	Oper. Margin	-	ATR (14)	7.80	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	50.02	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	42.58	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	50.02	EPS Q/Q	-51.84%	SMA20	-2.86%	Beta	-1.23	Target Price	210.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-8.24%	Rel Volume	3.56	Prev Close	148.00
Employees	41	LT Debt/Eq	0.00	Earnings	May 20 BMO	SMA200	8.37%	Avg Volume	158.63K	Price	144.18
IPO	Apr 29, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	46.45% -	Trades		Volume	565,172	Change	-2.58%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)